Sign in
MNZO Stock Price, Chart, Stats & News
Manzo Pharmaceuticals, Inc.
Save
Manzo Pharmaceuticals, Inc. (MNZO) does not currently pay a dividend.
115,952
Market cap
–
Current P/E
–
Forward P/E
MNZO chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Pharmaceuticals
Industry
Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the discovery, creation, and evaluation of both proprietary and generic medical treatments and therapies. The company is actively developing Lacto-Freedom, a patented probiotic designed to help individuals with lactose intolerance digest dairy-containing foods more easily. Additionally, it is crafting a natural solution for infant colic.
Similar securities
Based on sector and market capitalization
Report issue